Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01

被引：12

作者：

Ahn, M-J. ^{[1
]}

Lisberg, A. E. ^{[2
]}

Paz-Ares, L. ^{[3
]}

Cornelissen, R. ^{[4
]}

Girard, N. ^{[5
]}

Pons-Tostivint, E. ^{[6
]}

Vicente Baz, D. ^{[7
]}

Sugawara, S. ^{[8
]}

Cobo Dols, M. ^{[9
]}

Perol, M. ^{[10
]}

Mascaux, C. ^{[11
]}

Poddubskaya, E. ^{[12
]}

Kitazono, S. ^{[13
]}

Hayashi, H. ^{[14
]}

Sands, J. ^{[15
]}

Hall, R. ^{[16
]}

Zhang, Y. ^{[17
]}

Zebger-Gong, H. ^{[18
]}

Uema, D. ^{[19
]}

Okamoto, I. ^{[20
]}

机构：

[1] Samsung Med Ctr, Dept Med, Seoul, South Korea

[2] UCLA, Med David Geffen Sch Med, Los Angeles, CA USA

[3] Hosp Univ 12 Octubre, Med Oncol Dept Edificio Maternidad 2a Planta, Madrid, Spain

[4] Erasmus MC, Univ Med Ctr, Pulm Med, Rotterdam, Netherlands

[5] Inst Curie, Thorax Inst, Paris, France

[6] Univ Hosp Nantes, Dept Med Oncol, Nantes, France

[7] Hosp Univ Virgen Macarena, Med Oncol, Seville, Spain

[8] Sendai Kousei Hosp, Pulm Med Dept, Sendai, Miyagi, Japan

[9] Reg & Virgen Victoria Univ Hosp, Med Oncol Interctr Unit, IBIMA, Dept Med Oncol, Malaga, Spain

[10] Ctr Leon Berard, Dept Med Oncol, Lyon, France

[11] Univ Hosp Strasbourg, Dept Pulm, Strasbourg, France

[12] Vitamed LLC, Moscow, Russia

[13] Canc Inst Hosp JFCR, Thorac Med Oncol Dept, Koto Ku, Tokyo, Japan

[14] Kindai Univ, Sch Med Main Campus, Osaka, Japan

[15] Harvard Med Sch, Dana Farber Canc Inst, Thorac Med Oncol, Boston, MA USA

[16] Univ Virginia, Hematooncol Dept, Charlottesville, VA USA

[17] Daiichi Sankyo Inc, Basking Ridge, NJ USA

[18] Dauchi Sankyo Europe GmbH, Global Oncol Clin Dev, Munich, Germany

[19] Daiichi Sankyo USA, Oncol Res & Dev Dept, Parsippany, NJ USA

[20] Kyushu Univ, Dept Resp Med, Fukuoka, Japan

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.10.588

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

509MO

引用

页码：S1665 / S1666

页数：2

共 50 条

[21] Datopotamab Deruxtecan (Dato-DXd; DS-1062), a TROP2 ADC, in Patients With Advanced NSCLC: Updated Results of TROPION-PanTumor01 Phase 1 Study
Spira, A.
Lisberg, A.
Sands, J.
Greenberg, J.
Phillips, P.
Guevara, F.
Tajima, N.
Kawasaki, Y.
Gu, J.
Kobayashi, F.
Yamamoto, N.
Johnson, M.
Meric-Bernstam, F.
Yoh, K.
Garon, E.
Heist, R.
Shimizu, T.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S106 - S107
[22] Datopotamab Deruxtecan (Dato-DXd) in Advanced Triple-Negative Breast Cancer (TNBC): Updated Results From the Phase 1 TROPION-PanTumor01 Study
Bardia, Aditya
Krop, Ian
Meric-Bernstam, Funda
Tolcher, Anthony W.
Mukohara, Toru
Lisberg, Aaron
Shimizu, Toshio
Hamilton, Erika
Spira, Alexander I.
Papadopoulos, Kyriakos P.
Greenberg, Jonathan
Gu, Wen
Kobayashi, Fumiaki
Zebger-Gong, Hong
Kawasaki, Yui
Wong, Rie
Kogawa, Takahiro
CANCER RESEARCH, 2023, 83 (05)
[23] TROPION-Lung07: A phase III trial of datopotamab deruxtecan (Dato-DXd) plus pembrolizumab (pembro) with or without platinum chemotherapy (Pt-CT) as first-line (1L) therapy in advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC) with PD-L1 expression
Okamoto, I.
Kuyama, S.
Girard, N.
Lu, S.
Franke, F. A.
Pan, E.
Ren, N.
Chen, A.
Oputa, E.
Lisberg, A. E.
ANNALS OF ONCOLOGY, 2023, 34
[24] TROPION-PanTumor01: Dose analysis of the TROP2-directed antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd, DS-1062) for the treatment (Tx) of advanced or metastatic non-small cell lung cancer (NSCLC).
Meric-Bernstam, Funda
Spira, Alexander I.
Lisberg, Aaron Elliott
Sands, Jacob
Yamamoto, Noboru
Johnson, Melissa Lynne
Yoh, Kiyotaka
Garon, Edward B.
Heist, Rebecca Suk
Petrich, Adam
Greenberg, Jonathan
Tajima, Naoyuki
Kawasaki, Yui
Gu, Jessie
Kobayashi, Fumiaki
Lu, Yasong
Guevara, Ferdinand M.
Shimizu, Toshio
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[25] Datopotamab deruxtecan (Dato-DXd) in locally advanced/metastatic urothelial cancer: Updated results from the phase 1 TROPIONPanTumor01 study.
Alhalabi, Omar
Meric-Bernstam, Funda
Lisberg, Aaron
Drakaki, Alexandra
Garmezy, Benjamin
Kogawa, Takahiro
Spira, Alexander I.
Salkeni, Mohamad Adham
Gao, Xin
Tolcher, Anthony W.
Bhave, Manali A.
Doroshow, Deborah Blythe
Hoffman-Censits, Jeannie
Klauss, Gunnar
Kaga, Yoshiaki
Kakurai, Yasuyuki
Kojima, Takahiro
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
[26] Datopotamab Deruxtecan (Dato-DXd; DS-1062), a TROP2 ADC, in patients with advanced NSCLC: Updated results of TROPION-PanTumor01 phase 1 study
Shimizu, Toshio
Lisberg, Aaron E.
Sands, Jacob M.
Greenberg, Jonathan
Phillips, Penny
Tajima, Naoyuki
Kawasaki, Yui
Gu, Jessie
Kobayashi, Fumiaki
Yamamoto, Noboru
Johnson, Melissa
Meric-Bernstam, Funda
Yoh, Kiyotaka
Garon, Edward B.
Heist, Rebecca S.
Spira, Alexander
ANNALS OF ONCOLOGY, 2021, 32 : S285 - S285
[27] Datopotamab Deruxtecan in Advanced or Metastatic Non-Small Cell Lung Cancer With Actionable Genomic Alterations: Results From the Phase II TROPION-Lung05 Study
Sands, Jacob
Ahn, Myung-Ju
Lisberg, Aaron
Cho, Byoung Chul
Blumenschein, George, Jr.
Shum, Elaine
Pons Tostivint, Elvire
Goto, Yasushi
Yoh, Kiyotaka
Heist, Rebecca
Shimizu, Junichi
Lee, Jong-Seok
Baas, Paul
Planchard, David
Perol, Maurice
Felip, Enriqueta
Su, Wu-Chou
Zebger-Gong, Hong
Lan, Lan
Liu, Chelsea
Howarth, Paul
Chiaverelli, Rachel
Paz-Ares, Luis
JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (10)
[28] Datopotamab Deruxtecan (Dato-DXd) plus Durvalumab ± Carboplatin in Advanced/mNSCLC: Initial Results from Phase 1b TROPION-Lung04
Papadopoulos, K. P.
Bruno, D.
Kitazono, S.
Murakami, S.
Gutierrez, M.
Wakuda, K.
Spira, A.
Cuppens, K.
Lovick, S.
Hepner, A.
Mak, G.
Waqar, S. N.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S55 - S55
[29] Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study
Paz-Ares, Luis G.
Juan-Vidal, Oscar
Mountzios, Giannis S.
Felip, Enriqueta
Reinmuth, Niels
de Marinis, Filippo
Girard, Nicolas
Patel, Vipul M.
Takahama, Takayuki
Owen, Scott P.
Reznick, Douglas M.
Badin, Firas B.
Cicin, Irfan
Mekan, Sabeen
Patel, Riddhi
Zhang, Eric
Karumanchi, Divyadeep
Garassino, Marina Chiara
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (24)
[30] TROPION-Lung07: Phase III study of Dato-DXd plus pembrolizumab ± platinum-based chemotherapy as 1L therapy for advanced non-small-cell lung cancer
Okamoto, Isamu
Kuyama, Shoichi
Girard, Nicolas
Lu, Shun
Franke, Fabio
Li, Ziming
Danchaivijitr, Pongwut
Han, Ji-Youn
Sun, Jong-Mu
Sugawara, Shunichi
Pan, Edward
Ren, Natalie
Chen, Aiying
Rajagopalan, Rachana
Lisberg, Aaron E.
FUTURE ONCOLOGY, 2024, 20 (37) : 2927 - 2936

← 1 2 3 4 5 →